| NANOFORM FINLAND OYJ |
| Finnland |
| Gesundheit |
| FI4000330972 / A2P5N7 |
| 4YL (Frankfurt) |
| FRA:4YL, ETR:4YL, 4YL:GR |
| - |
| https://nanoform.com/ |
|
Nanoform Finland Plc is a biotechnology company that specializes in innovative drug delivery solutions. Its primary function is to enhance the bioavailability and efficacy of pharmaceutical compounds through its proprietary nanoparticle technology. T..
>Volltext.. |
| 35.56 Mio. EUR |
| 17.98 Mio. EUR |
| 3.57 Mio. EUR |
| -18.81 Mio. EUR |
| -18 Mio. EUR |
| -0.21 EUR |
| 6.25 Mio. EUR |
| 24.14 Mio. EUR |
| -17.96 Mio. EUR |
| 3.91 |
| 27.67% |
| 23.6% |
| - |
| - |
| - |
| - |
| NANOFORM |
| 08.04.26 |
|
||||
|
||||
|
||||
|
||||
|